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Abstract
The stress hormone cortisol has been recognized as a coordinator of immune response.
However, its different ability to modulate the release of inflammatory mediators in males and
females has not been clarified yet. Indeed, the dissection of cortisol specific actions may be
difficult due to the complex hormonal and physio-pathological individual status. Herein, the
release of inflammatory mediators following increasing cortisol concentrations was investi-
gated in an in vitro model of primary human male and female lymphomonocytes. The use of
a defined cellular model to assess sex differences in inflammatory cytokine secretion could
be useful to exclude the effects of divergent and fluctuating sex hormone levels occurring in
vivo. Herein, the cells were challenged with cortisol concentrations resembling the plasma
levels achieving in physiological and stressful conditions. The production of cytokines and
other molecules involved in inflammatory process was determined. In basal conditions,
male cells presented higher levels of some pro-inflammatory molecules (NF-kB and IDO-1
mRNAs, IL-6 and kynurenine) than female cells. Following cortisol exposure, the levels of
the pro-inflammatory cytokines, IL-6 and IL-8, were increased in male cells. Conversely, in
female cells IL-6 release was unchanged and IL-8 levels were decreased. Anti-inflammatory
cytokines, IL-4 and IL-10, did not change in male cells and increased in female cells. Inter-
estingly, kynurenine levels were higher in female cells than in male cells following cortisol
stimulus. These results highlighted that cortisol differently affects male and female lympho-
monocytes, shifting the cytokine release in favour of a pro-inflammatory pattern in male cells
and an anti-inflammatory secretion profile in female cells, opening the way to study the influ-
ences of other stressful factors involved in the neurohumoral changes occurring in the
response to stress conditions.
Introduction
Sex has been reported as one of the several variables interfering with the occurrence and sever-
ity of stress-related disorders. Men are more predisposed to infectious diseases, hypertension,
drug abuse and aggressive behaviour. On the other hand, conditions such as autoimmune dis-
eases, chronic pain, anxiety disorders and depression are prevalent among women [1–4]. The
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differences in stress reactivity have been proposed as an important risk factor for such sex-spe-
cific diseases [5–6]. Differences based on sex in response to stress have been occasionally
reported in healthy subjects too. These responses are related both to the type and time of stress
exposure, and to the pathophysiological and hormonal status of the individuals [7–8]. In such
a complex background, the papers are numerous but the data are sometimes controversial.
Therefore, it is important to provide data obtained from well-controlled experimental settings
to shed light on the molecular mechanisms at the heart of stress responses. A cellular model
could be also useful to control the divergent and fluctuating sex hormone levels occurring in
vivo that could affect the stress responses. A defined in vitro model, previously used to assess
the alteration of immune response secretion following stress-mimicking conditions, is the
human cell culture of peripheral blood mononuclear cells (PBMCs) exposed to cortisol. Corti-
sol is the major stress hormone and it has been recognized as a modulator of inflammatory
responses. In literature, PBMCs have been exposed to stress-mimicking settings and alter-
ations of cytokine secretion have been observed [9–10]. In light of this, the purpose of the
study was the assessment of male and female PBMCs responses following cortisol treatment.
In particular, the cells were exposed to a low cortisol concentration, simulating the physiologi-
cal cortisol level, and to a higher cortisol concentration similar to that occurring in plasma fol-
lowing acute stress. Through immune-enzymatic assays and real-time reverse transcription
polymerase chain reaction (real-time RT-PCR) techniques, interleukins (the pro-inflammatory
interleukins, IL-6 and IL-8, and the anti-inflammatory interleukins, IL-4 and IL-10) and other
molecules involved in inflammatory processes (NF-kB transcription factor, indoleamine
2,3-dioxygenase 1 -IDO-1- and kynurenine -Kyn-) were investigated. The results showed sig-
nificant differences between male and female PBMCs responses under cortisol exposure.
Materials and methods
Materials
The frozen human peripheral blood mononuclear cells were obtained from Zen-Bio Inc.
(Research Triangle Park, NC, USA). As the European Pharmacopoeia’s guideline recommen-
dation for a cellular test investigating cytokine output (the monocyte-activation test (2.6.30)
published in the European Pharmacopoeia Supplement 9.2), each PBMC pools (male and
female PBMCs) was prepared from four healthy donors, in order to reduce the effects of donor
variability. Healthy donors were matched for race (Caucasian) and age (31±3). Each cryovial
contained similar content of lymphocytes and monocytes, as reported in the furnished data
sheets (lymphocytes = 89.35% ± 1.91; monocytes = 10,65% ± 1.91).
Cell culture media and foetal bovine serum were obtained from Cambrex Bio Science
Walkersville, Inc. (Walkersville, MD). Cortisol (HC, hydrocortisone98% (HPLC), powder)
was obtained from SIGMA Italia (Milan, Italy). The Human IL-6 ELISA Kit, Human IL-10
ELISA Kit and Human IL-8 ELISA Kit were obtained from Thermo Fisher Scientific Inc.
(Rockford, USA). The Human IL-4 ELISA Kit was obtained from Cloud Clone Corp (Katy,
USA). The Human KYN ELISA Kit was obtained from Cusabio Biotech Co (Baltimore Ave-
nue, College Park, USA). All other reagents were from standard commercial sources.
Cell culture, treatments and preparations
The human male and female PBMCs were defrosted in RPMI 1640 medium supplemented
with 10% foetal bovine serum, 2 mM of L-glutamine, 100 U/ml of penicillin, and 200 microg/
ml of streptomycin, distributed in 24-well multiplates (5 x 105 cells/well) or in 10 cm-dishes (5
x 106 cells) and maintained in a humidified atmosphere of 95% air/5% CO2 at 37˚C. After 24
hours, PBMCs were treated with increasing concentrations of cortisol in the serum free cell
Sex differences in cytokine responsiveness following cortisol challenge
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medium. Hydrocortisone stock solutions were prepared by dissolving HC in ethanol and then
diluting with pyrogen-free sterile saline solution (NaCl 0.9%) to achieve equipotent final cul-
ture concentrations of 0.2 microg/ml (physiological plasma cortisol level) and 0.4 microg/ml
(plasma cortisol level in high-stress status) [11]. PBMCs were added with NaCl 0.9% (control)
and treated with ethanol 0.1% or cortisol to final cortisol concentrations of 0, 0.2 and 0.4
microg/ml.
Following a 16 h incubation period, cells were collected and centrifuged for 10 min at
2000xg at 4˚C. Such an incubation period was needed to achieve the optimal expression of
inflammatory molecules, as indicated by previous time course experiments [12]. The superna-
tant was collected and stored at -80˚C until assayed. Aliquots of cells were suspended in an
appropriate buffer (phosphate saline buffer containing a protease inhibitor cocktail) and lysed
through multiple freeze/thaw cycles. The homogenates were centrifuged for 5 min at 5000xg at
4˚C, and the supernatant was collected. Protein concentrations of cell supernatants and cell
lysates were estimated by the method described by Lowry et al. [13] using bovine serum albu-
min as a standard. Lysates were collected and stored at -80˚C until assayed. Other aliquots of
cells were immediately processed for the RNA isolation using the RNeasyH Mini Kit.
Cytokine assays. Supernatant levels of IL-6, IL-10, IL-8 and IL-4 were determined using
commercial enzyme-linked immunosorbent assay (ELISA). The most highly sensitivity ELI-
SAs were chosen to measure the concentrations of IL-6 (Thermo Fisher Scientific Inc., detec-
tion range: 10.2 to 400pg/mL, sensibility < 1 pg/mL), IL-10 (Thermo Fisher Scientific Inc.,
detection range: 15.4 to 600 pg/mL, sensibility < 3 pg/mL), IL-8 (Thermo Fisher Scientific
Inc., detection range: 25.6 to 1000 pg/mL, sensibility < 2 pg/mL), and IL-4 (Cloud Clone
Corp., detection range: 15.6–1000 pg/mL, sensibility < 5.7 pg/mL).The effect of cortisol treat-
ment on the rate of cytokine secretions was measured.
Cytokine Secretion Impact (CSI). To better visualize the cortisol effects on cytokine pro-
duction, the results were analysed in an integrated fashion (multi-cytokine sensor). This
approach was developed from a similar method used to discriminate the quality of specific
water samples [14]. The sensors were used to calculate the Index of Cytokine Secretion Impact
(CSI), using ImageJ software (National Institute of Mental Health, Bethesda, Maryland, USA).
The CSI represents the ratio between the secretion of inflammatory (IL-6 and IL-8) and anti-
inflammatory (IL-4 and IL-10) cytokines. Briefly, data were represented using the Radar Plot
on Microsoft Excel 2010. Radar plots were generated by reporting the IL-6, IL-10, IL-4 and IL-
8 mean values as a set of points (interleukin points) plotted along a set of axes radiating from a
central point. The interleukin points were connected by a line. The areas under the curve
(AUC) were obtained by ImageJ analyses, and the ratio pro-/anti-inflammatory effects were
calculated. For a 0<CSI<1, the cytokine secretion profile of PBMC is mainly anti-inflamma-
tory; for a CSI>1, the cytokine secretion profile is primarily inflammatory.
This analysis enabled us to dissect the sex impact on pro-inflammatory or anti-inflamma-
tory cytokine secretion profiles during stimulation of different cortisol concentrations.
Relative mRNA quantification of NFkB and IDO-1 genes. The relative quantification of
interleukins, NFkB and IDO-1 mRNA was performed by real-time RT-PCR as previously
described [15] in PBMCs. In brief, total RNA was isolated using the RNeasy Mini Kit (Quia-
gen). The purity of the RNA samples was determined by measuring the absorbance at 260:280
nm. cDNA synthesis was performed with 500 ng of RNA using the iScript cDNA Synthesis Kit
(Bio Rad). The primers used for the RT-PCR were designed to span intron/exon boundaries to
ensure that products did not include genomic DNA (Table 1).
The RT-PCR reactions consisted of 25 microL of BrilliantH II SYBRH Green premix, 1.5
microL of both the forward and reverse primers (at a 10 mM concentration), 3 microL of
cDNA and 19 microL of H2O. All reactions were performed for 40 cycles using the following
Sex differences in cytokine responsiveness following cortisol challenge
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temperature profiles: 98˚C for 30 seconds (initial denaturation), 55˚C for 30 seconds (anneal-
ing) and 72˚C for 3 seconds (extension). Beta-actin was used as the housekeeping gene. PCR
specificity was determined using both a melting curve analysis and gel electrophoresis, and the
data were analysed by the standard curve method. Interleukins, NFkB and IDO-1 mRNA levels
for each sample were normalised against beta-actin mRNA levels, and relative expression was
calculated using the Ct value.
Kynurenine quantification. The Human KYN ELISA Kit from Cusabio Biotech Co. was
used to quantify the Kyn amount in cellular lysates, according to manufacturer’s instructions.
The detection range of the kit was 0.12–500 pmol/ml, and the sensitivity was 0.12 pmol/ml.
Kyn concentration was normalized to the protein content; the rationale for this correction is
the fact that the lysing process caused a great variation among lysates in protein content.
Statistical analyses. All calculations were performed using Excel 2013 and the nonlinear
multipurpose curve-fitting program GraphPad Prism that was also used for statistical analysis
and graphic presentations. AUC for CSI calculation were obtained by the use of the open
source Java image processing program ImageJ. All data are presented as the means ± SEM. Sta-
tistical analysis was performed by a t-test or a one-way analysis of variance (ANOVA) with the
Newman-Keuls multiple comparison test for post hoc pair-wise comparisons. Two-way
ANOVA analyses were also performed to determine how the responses were affected by sex
and cortisol concentrations. The results were considered significant at the p<0.05 level.
Results
Pro-inflammatory cytokine production in cortisol treated PBMCs
Male and female PBMCs were exposed to different cortisol concentrations mimicking physio-
logical cortisol levels. In particular, the 0.2 and 0.4 microg/ml doses were chosen to resemble
the normal plasma cortisol level and the cortisol level in highly stressed persons, respectively,
in accordance with previous literature [16].
The levels of pro-inflammatory cytokines were first assessed in unstimulated PBMCs
evidencing that the levels of IL-6 in basal condition were significantly higher in male (striped)
than in female (in white) PBMCs (Fig 1A; , p<0.001), whereas the IL-8 did not show sex-
related differences (Fig 1B). Following physiological cortisol stimulation, the IL-6 levels were
not significantly changed in female cells (in white), while in male PBMCs cortisol caused a
Table 1. Nucleotide sequences, product size and annealing temperature of the primers utilized in real-time RT-PCR experiments.
Gene Primer nucleotide sequences Product size
(base pairs)
Annealing
Temperature
IL-6 FOR: 50-TCCTCGACGGCATCTCA-30
REV: 50-TTTTCACCAGGCAAGTCTCCT-30
165 bp 55˚C
IL-8 FOR: 50-AAGAGAGCTCTGTCTGGACC-30
REV: 50-GATATTCTCTTGGCCCTTGG-30
408 bp 56˚C
IL-10 FOR: 50-CAAGCTGAGAACCAAGACCC-30
REV: 50-AAGATGTCAAACTCACTCATGGC-30
141 bp 55˚C
IL-4 FOR: 50-ACTTTGAACAGCCTCACAGAG-30
REV: 50-TTGGAGGCAGCAAAGATGTC-30
74 bp 56˚C
NFkB FOR: 50-CAGCAGATGGCCCATACCTT-30
REV: 50-CACCATGTCCTTGGGTCCAC-30
287 bp 55˚C
IDO-1 FOR: 50-GATGAAGAAGTGGGCTTTGC-30
REV: 50-TCCAGTTTGCCAAGACACAG-30
352 bp 55˚C
beta-actin FOR: 50-GCACTCTTCCAGCCTTCCTTCC-30
REV: 50-GAGCCGCCGATCCACACG-30
254 bp 55˚C
https://doi.org/10.1371/journal.pone.0200924.t001
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significant immunosuppressive effect (#, p<0.05 vs not stimulated condition) (Fig 1A), despite
the levels remaining significantly higher with respect to the female cells. Interestingly, follow-
ing the highest cortisol treatment, the IL-6 release in female PBMCs was not affected. In con-
trast, such a concentration of cortisol in male cells was able to increase the IL-6 secretion with
respect to physiological cortisol (˚˚ p<0,01, Fig 1A). Two-way ANOVA tests confirmed the
differences in the cortisol treatment for the IL-6 release between the two sexes; the interaction
is considered extremely significant (Interaction P value = 0.0001; F = 19.50; DFn = 2).
In order to dissect the mechanism at the basis of cortisol effects, the IL-6 and IL-8 gene
expression was also evaluated (Fig 1B and 1D). In particular, the IL-6 mRNA levels were com-
parable to the cytokine secretion in female cells. Conversely, the intracellular gene expression
of IL-6 in male cells was significant increase. The data confirmed that cortisol was able to dif-
ferently modulate the expression of IL-6 based on sex.
Fig 1. Pro-inflammatory interleukin secretion and gene expression following cortisol challenges. The white bars represent the mean ± SEM of three values
performed in triplicate in female PBMCs; the striped bars represent the mean ± SEM of three values performed in triplicate in male PBMCs.  p<0.001 vs female cells
(t-test); # p<0.05 or ### p<0.001 vs not-stimulated male cells (One-way Anova, Newman-Keuls post test); § p<0.05 vs not-stimulated female cells (One-way Anova,
Newman-Keuls post test); c¸c¸ p<0.01 vs 0.2 microg/ml cortisol treated female cells (t-test); ˚˚ p<0.01 or ˚˚˚ p<0.001 vs 0.2 microg/ml cortisol treated male cells (t-test).
For IL-6, Two-way ANOVA test (sex x treatment): interaction p value = 0.0001; F = 19.50; DFn = 2. For IL-8, Two-way ANOVA test (sex x treatment): interaction p
value< 0.0001; F = 392.7; DFn = 2.
https://doi.org/10.1371/journal.pone.0200924.g001
Sex differences in cytokine responsiveness following cortisol challenge
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Then, the levels of the pro-inflammatory cytokine IL-8 were assessed (Fig 1C). IL-8 is a
cytokine produced by mononuclear cells that is involved in cellular recruitment and activation
[17], and it is released from PBMCs during the first hours of an infection [18]. As reported in
Fig 1, panel c, unstimulated male and female PBMCs did not show differences in IL-8 levels.
Under physiological cortisol treatment, cells of both sexes increased IL-8 secretion but with
different extents; male cells produced higher levels of interleukin with respect to female cells
(§, p<0.05 in female PBMCs; ###, p<0.001). Furthermore, in the presence of the highest corti-
sol concentration, female cells significantly decreased IL-8 secretion (c¸c¸, p<0.01), while male
PBMCs further increased the IL-8 levels with respect to physiological cortisol stimulation (˚˚˚,
p<0.001). These data were completely in accordance with the ability of cortisol to modulate
the IL-8 gene expression (Fig 1D).
Two-way ANOVA analyses proved that the cortisol treatments affect male and female cell
responses differently; the interaction was considered extremely significant (interaction p
value < 0.0001; F = 392.7; DFn = 2).
Anti-inflammatory cytokine productions in cortisol treated PBMC
To further investigate the modulation of PBMC secretions under different cortisol concentra-
tions, the levels of the anti-inflammatory cytokines IL-10 and IL-4 were investigated. Both the
interleukins did not show sex-related differences in unstimulated cells (Fig 2).
Following physiological cortisol stimulation, the IL-10 release by female PBMCs was not
significantly affected, while in male cells, cortisol demonstrated immunosuppressive effects (#,
p<0.05 vs not stimulated condition) (Fig 2A). The highest cortisol concentration caused a sig-
nificant IL-10 increase in female cells (˚, p<0.05 vs physiological cortisol; Fig 2A) and only a
slight increase in male cells. Two-way ANOVA test demonstrated that the cortisol had differ-
ent effects in males and females; the interaction was considered very significant (interaction p
value = 0.0043; F = 7.64; DFn = 2). In accordance with these data, cortisol was able to increase
the expression of IL-10 in female cells with different extent based on cortisol concentrations
(Fig 2B). Conversely, the hormone was able to slightly decrease the IL-10 production in male
cells, explaining the decrease of the cytokine release.
IL-4 has anti-inflammatory properties in monocytes [19]. A physiological cortisol concen-
tration was able to increase the IL-4 secretion in female PBMCs (§, p<0.05, Fig 2B); on the
contrary, male cells did not show significant differences in the IL-4 levels (Fig 2C). The highest
cortisol concentration did not significantly affect the IL-4 release pattern in both sexes with
respect to the physiological response; in female cells, a significant increase was evidenced. Con-
versely, in male cells, there was only a slight change. These trends were in accordance with the
gene expression pattern of IL-4 (Fig 2D) in both sexes. The two-way ANOVA tests indicated
no sex difference for IL-4 following cortisol treatment (p = 0.2402; F = 1.51; DFn = 2).
Determination of the pro- and anti-inflammatory cytokine balance using
the multi-cytokine sensor
The multi-cytokine sensor reported in this study allowed the investigation of the balance
between inflammatory and anti-inflammatory interleukins secreted by PBMCs following cor-
tisol treatment. The response of the multi-cytokine sensor was evaluated in the absence or
presence of different cortisol concentrations, plotting the data obtained in male (blue line) and
female (pink line) PBMCs (Fig 3). The results of unstimulated cells (Fig 3A), cells treated with
physiological cortisol concentration (Fig 3B) and cells treated with the highest cortisol concen-
tration (Fig 3C) were reported. It was evident that the secretion pattern of male cells had a
trend in favour of pro-inflammatory cytokines in the presence of increasing cortisol
Sex differences in cytokine responsiveness following cortisol challenge
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concentrations. On the contrary, female cells produced a more pronounced anti-inflammatory
secretion pattern in the presence of increasing cortisol concentrations.
Then, the multi-cytokine sensors were analysed using ImageJ software to calculate the CSI
index. Data are reported in Table 2.
As reported in Table 2, PBMCs increased the cytokine release in response to increasing
concentrations of cortisol, as attested by the rise in total area values in response to cortisol
doses. In particular, this increase was more evident in male cells with respect to female cells.
Furthermore, the CSI values highlighted that cortisol treatment, and in particular, the high-
est concentration, oppositely affected male and female cells, shifting the cytokine release in
Fig 2. Anti-inflammatory interleukin secretion and gene expression following cortisol challenges. The white bars represent the mean ± SEM of three values
performed in triplicate in female PBMCs; the striped bars represent the mean ± SEM of three values performed in triplicate in male PBMCs. § p<0.05 vs not-stimulated
female cells (One-way Anova, Newman-Keuls post test); # p<0.05 vs not-stimulated male cells (One-way Anova, Newman-Keuls post test); c¸ p<0.05 vs 0.2 microg/ml
cortisol treated female cells (t-test). For IL-10, Two-way ANOVA test (sex x treatment): interaction p value = 0.0043; F = 7.64; DFn = 2. For IL-4, Two-way ANOVA test
(sex x treatment): interaction p value = 0.2402; F = 1.51; DFn = 2.
https://doi.org/10.1371/journal.pone.0200924.g002
Sex differences in cytokine responsiveness following cortisol challenge
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Fig 3. Use of multi-cytokine sensors analyse the balance between pro- and anti-inflammatory cytokine release following cortisol challenges. A) pro-/anti-
inflammatory balance in non-stimulated PBMCs; B) pro-/anti-inflammatory balance in physiological cortisol-stimulated PBMCs; C) pro-/anti-inflammatory balance in
high cortisol-stimulated PBMCs. Pro-inflammatory interleukins are represented in red; anti-inflammatory interleukins are represented in green. The orange line
represents the border between the anti- (under) and pro- (above) inflammatory secretion areas.
https://doi.org/10.1371/journal.pone.0200924.g003
Table 2. Values of the CSI index.
Cell Treatment Condition Sex Total area PI area AI area CSI
Non-stimulated cells
(0 microg/ml)
Male 0.427 0.132 0.285 0.463
Female 0.264 0.027 0.246 0.110
Physiological cortisol
(0.2 microg/ml)
Male 0.597 0.410 0.194 2.113
Female 0.356 0.069 0.292 0.236
Acute stress cortisol
(0.4 microg/ml)
Male 1.634 1.390 0.274 5.073
Female 0.489 0.042 0.456 0.092
The values are reported as the ratio between the secretion areas of pro-inflammatory (IL-6 and IL-8), PI, and anti-inflammatory (IL-4 and IL-10), AI, cytokines. For
0<CSI<1, the cytokine secretion profile of PBMC is mainly anti-inflammatory; for CSI>1, the cytokine secretion profile is principally pro-inflammatory.
https://doi.org/10.1371/journal.pone.0200924.t002
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favour of a pro-inflammatory secretion profile in male cells and of an anti-inflammatory secre-
tion profile in female lymphomonocytes. In fact, in the presence of both cortisol concentra-
tions, the CSI index were <1 for female and>1 for male (Table 2).
IDO-1 expression and kynurenine production in cortisol treated PBMC
The enzyme IDO-1 is constitutively expressed in blood monocytes [20], and inflammatory
cytokines such as interferon, IL-1 beta and IL-6 during an immune response are able to
increase its expression [21]. IDO-1 catalyses the first and rate-limiting step of tryptophan oxi-
dation and creates an immunosuppressive microenvironment decreasing the levels of the
essential amino acid tryptophan and producing immunosuppressive tryptophan metabolites
such as kynurenine [22]. IDO-1 has been generally considered an important counter-regula-
tory enzyme, which controls disproportionate immune responses [23].
The relative IDO-1 mRNA expression in male and female PBMCs was performed by real-
time RT-PCR analysis (Fig 4). In accordance with basal IL-6 levels, male PBMCs presented
higher levels of IDO-1 with respect to female PBMCs (1.5-fold of the change vs female 
p<0,001) (Fig 4A). Physiological cortisol concentration did not affect the female IDO-1
mRNA expression; conversely, it was able to significantly increase the IDO-1 gene expression
in male PBMCs (Fig 4B; p<0.05). Furthermore, the highest cortisol concentration produced a
significant increase in the enzyme expression in female cells (p<0.01) and a significant
decrease in male cells (p<0.01). Additionally, the two-way ANOVA test proved the different
cortisol effects in male and female cells; the interaction was considered extremely significant
(interaction P value < 0.0001; F = 14.35; DFn = 2). These results are in accordance with the
pro-inflammatory secretion pattern shown by the male cells (Fig 3).
As IDO-1 catalyses the rate-limiting step of tryptophan oxidation yielding kynurenine, Kyn
levels were assessed in the cell lysates. Kyn in the basal condition was significantly higher in
male than in female PBMCs (, p<0.01), completely in accordance with the results of IDO-1
mRNA basal expression. Furthermore, in accordance with IDO-1 gene expression, male and
female PBMCs showed a significant increase in kynurenine levels in the presence of a physio-
logical cortisol concentration (Fig 4). Notably, female PBMCs treated with the highest cortisol
concentration released higher levels of kynurenine than male cells. Despite the decrease of
IDO-1 gene expression, in male PBMCs, the highest cortisol concentration produced a signifi-
cant release of Kyn. The two-way ANOVA test confirmed the differences between the two
sexes; the interaction was considered extremely significant (interaction p value = 0.0005;
F = 14.35; DFn = 2).
Discussion
Men and women report different reactions to physical and mental stress [24]. Only few papers
have described the sex influence on stress-mediated cytokine release in clinical studies and in
in vivo models [25–31]. These data are difficult to compare, due to the intricate neurohumoral
changes occurring in the response to acute stress conditions and to the difference in the exper-
imental models and settings. In addition, the measurement of plasma cytokines is often not
reliable since cytokine levels in vivo are frequently undetectable or highly variable. It has been
reported that in vitro models provide more useful information about stimulus effects on spe-
cific cytokine production [32, 33]. In this light, the current study aimed to investigate the role
of cortisol in stress-induced cytokine secretions using an in vitro cellular model. Previous
research has been conducted in a similar PBMC model to investigate cytokine production in
response to external agents [18, 34, 35]. Herein, pools of male and female PBMCs containing
similar content of lymphocytes and monocytes were used as a valuable in vitro cellular model.
Sex differences in cytokine responsiveness following cortisol challenge
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In literature, the leukocyte count has been found similar between men and women, less then
slightly higher proportion of eosinophils in men, and gender-related differences were not
apparent for the monocyte cells [36, 37]. Furthermore, it has been reported that women had
shown a slightly higher ratio of CD4 + to CD8 + cells (helper-suppressor ratio) than men.
Interestingly, a low CD4/CD8 ratio is an immune risk phenotype [38–41]. However, a wide
Fig 4. IDO-1 mRNA expression and kynurenine production following cortisol challenges. The white bars represent the mean ± SEM of three values performed in
triplicate in female PBMCs; the striped bars represent the mean ± SEM of three values performed in triplicate in male PBMCs.  p<0.001 or  p<0.01 vs female cells
(t-test); § p<0.05 vs non-stimulated female cells (One-Way Anova, Newman-Keuls post-test); # p<0.05 or ## p<0.01 or ### p<0.001 vs non-stimulated male cells (One-
Way Anova, Newman-Keuls post-test); c¸c¸ p<0.01 or c¸c¸c¸ p<0.001 vs 0.2 microg/ml cortisol treated female cells (t-test); ˚˚ p<0.01 vs 0.2 microg/ml cortisol treated male
cells (t-test). For IDO-1, Two-way ANOVA test (sex, treatment): interaction P value< 0.0001; F = 14.35; DFn = 2. For Kyn, Two-way ANOVA test (sex, treatment):
interaction p value = 0.0005; F = 14.35; DFn = 2.
https://doi.org/10.1371/journal.pone.0200924.g004
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heterogeneity exists because not only sex, but also age, ethnicity, genetics, exposures, and
infections may all affect the ratio [42–45].
The basal levels of cytokine production by PBMCs in our model were in accordance with
the results in the literature. Such a model could allow for an accurate investigation of the
stress-related modulation in cytokine secretion associated with sex. Interestingly, to the best of
our knowledge, this is the first study that used a defined in vitro healthy PBMC model to assess
the sex differences in cytokine secretion profiles following cortisol exposure. The sex-related
differences in the inflammatory responses are widely documented in humans [46]; sex hor-
mones affect innate immune cells modulating immune responses during infections [46–48].
Interestingly, genetic factors have been proposed in the orchestration of cytokine secretions.
Indeed, some inflammation-related genes are expressed on sex chromosomes [49–51]. In addi-
tion, quantitative and qualitative differences in the cytokine release have been found in male
and female children, suggesting that sex hormones are not the only factor responsible for sex
differences [52]. In this light, a purpose of the present study was to investigate the cellular
response excluding divergent and fluctuating sex hormone levels to focus the attention on spe-
cific genetic sex-related differences.
Cytokines may have different pro- or anti-inflammatory effects [53]. For instance, IL-6 is
one of the major pro-inflammatory cytokines released during the first minutes after an injury,
and it has been widely accepted as a marker of acute immune system activation [54]; IL-10 is
an anti-inflammatory cytokine with pleiotropic effects in immunoregulation and inflamma-
tion [55]. Our data evidenced that following the cortisol challenge, male cells showed a secre-
tion profile more directed to pro-inflammatory cytokines; indeed, an increase in IL-6 and IL-8
cytokine secretion was evidenced. In contrast, female PBMCs displayed a more pronounced
anti-inflammatory secretion pattern, in fact in the presence of increasing cortisol concentra-
tions a consistent IL-4 and IL-10 release was evidenced. These data are in line with the obser-
vations of Wolf and colleagues [56] reporting a higher stress response in males than in females.
In addition, in our cellular model, male PBMCs generally secreted more cytokines with respect
to female PBMCs; this is consistent with several previous in vitro, ex vivo and in vivo studies,
demonstrating the production of greater levels of cytokines by male cells [57–65].
Actually, the cytokine secretion profile is regulated by complex control machinery to main-
tain a proper balance among inflammatory mediators. For instance, IL-10 has been previously
demonstrated to inhibit the production of pro-inflammatory cytokines, such as IL-6 [66–67].
Additionally, the capacity to downregulate the production of IL-8 has been demonstrated for
IL-4 and IL-10 in human PBMCs [68]. These findings may explain the cytokine levels found in
our models; the cortisol treatments were able to increase the IL-4 and IL-10 secretion in female
PBMCs, and these cytokines could in turn maintain lower levels of IL-6 and IL-8. In contrast,
in male cells, the anti-inflammatory cytokines did not increase in response to cortisol, and
thus they could not downregulate the pro-inflammatory cytokines.
Concerning the kynurenine pathway, inflammatory cytokines secreted during an immune
response are able to increase the expression of IDO-1 that, in turn, creates an immunosuppres-
sive microenvironment producing kynurenine [21,22]. Thus, IDO-1 has been generally con-
sidered an important counter-regulatory enzyme, which controls disproportionate immune
responses [23]. The link between IDO-1 and cytokines is very complex; for example, IL-6 con-
trols both the synthesis and degradation of IDO-1 [69]. In this light, the relation between
inflammatory response and IDO-1 activity is mediated by multiple factors, especially when the
system is perturbed with an external treatment or in pathological conditions. Indeed, at the
baseline condition, in which the system is not perturbed by cortisol treatment, the higher level
of IL-6 found in male cells corresponds to the higher level of IDO1 and Kyn (Fig 4).
Sex differences in cytokine responsiveness following cortisol challenge
PLOS ONE | https://doi.org/10.1371/journal.pone.0200924 July 26, 2018 11 / 16
Our data are in agreement with a previous study demonstrating that high concentrations of
hydrocortisone and the cortisol analogous dexamethasone induced IDO-1 in human astrocytic
cells [70]. In our model, a physiological cortisol concentration significantly increased the IDO-
1 gene expression in male PBMCs; the highest cortisol concentration produced a significant
increase in IDO-1 in female PBMCs but a significant decrease in male cells. Accordingly, with
the male data, it has been recently demonstrated that a decrease in IDO-1 activity causes the
overall production of pro-inflammatory cytokines, with a concomitant decrease in IL-10 [23].
Finally, female PBMCs treated with the highest cortisol concentration presented a kynure-
nine level almost double than that obtained in male cells. This finding may be of interest as the
increased synthesis of detrimental tryptophan catabolites, such as kynurenine, may contribute
to the onset of depression [71]. Indeed, it is well known that depression, stress and sex are
strictly correlated; depression may be both a cause and an effect of psychological stress, and
the occurrence of depression is more common in women than in men [72].
In conclusion, these results demonstrated the ability of cortisol to modulate differently the
cytokine release pattern of male and female healthy PBMCs. In particular, the highest cortisol
concentration affects male and female cells differently, shifting the cytokine release in favour
of pro-inflammatory and anti-inflammatory molecule secretion profiles, respectively. Never-
theless such interesting results, some limitations of the study should be considered; for exam-
ple, these findings could not be directly translate to clinic because isolated PBMC could
respond differently from the whole blood. Furthermore, these data could be implemented by
the cell model supplementation of other factors involved in stress conditions. Indeed, in
humans, stress causes the activation of both the HPA axis and the sympathetic nervous system,
resulting in the increase of also other neuroendocrine hormones, such as ACTH, CRH,
somatostatin, catecholamines, and endogenous opioids that could in turn influence the cyto-
kine release [73]. Moreover, in the complex in vivo response to stressors, the secreted cortisol
concentrations depend on sex; recently, a study investigating young adults exposed to mental
arithmetic plus public speaking stress has evidenced that women had lower amount of salivary
cortisol levels than men [74]. Although additional studies investigating the sex-specific effects
of neuroendocrine hormones in high stress will be needed, the current study provides useful
information on the effects of sex on cytokine release induced by cortisol.
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